Development of Cell-Assembled Human Endomysial-Type Biomatrix Substrate for the Detection of Celiac Disease Autoantibodies
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26031012 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ilma R Korponay-Szabó und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary. Hauptthemen laut MEDLINE: Celiac Disease, Autoantibodies, Extracellular Matrix. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union Interreg Danube Transnational Programme, European Union.
Abstract (Originalsprache)
The endomysial antibody (EMA) immunofluorescent test is a highly specific method to detect disease-specific autoantibodies in celiac disease (CD) by their binding to natural transglutaminase-2 autoantigen in tissue sections, and it is used as a compulsory confirmatory test in the non-invasive diagnosis of CD. The classical EMA substrates are the monkey esophagus and the human umbilical cord. It is increasingly difficult to use these tissues due to ethical concerns and animal welfare regulations. In this study, we developed, in cell culture, an endomysium-type extracellular biomatrix assembled by human umbilical cord vein-derived endothelial cells which binds CD antibodies in a similar pattern as monkey esophagus and has similar macromolecular composition. Evaluating retrospectively and prospectively tested patient cohorts, including 130 CD cases and 105 non-celiac controls, IgA-class celiac antibody detection on the biomatrix was equally specific (100%) as EMA testing on tissues, and had higher sensitivity (95.6% versus 91.2%). Both EMA tests were less sensitive, but more specific than transglutaminase-based ELISA measurements. The decellularization of the biomatrix improved sensitivity, enabled the detection of IgG-class celiac antibodies, and allowed for simple reading without previous training. This easily available cell-assembled biomatrix substrate may replace substrate tissues in diagnostic EMA testing in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
- Celiac Disease Center, Heim Pál National Pediatric Institute, 1089 Budapest, Hungary.
- Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
- Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
ORCID-Profile: Ilma R Korponay-Szabó, Róbert Király
Förderung
- European Union Interreg Danube Transnational Programme
- European Union
Zitieren
APA
Korponay-Szabó, I. R., Király, R., Gyimesi, J., & Mäki, M. (2025). Development of Cell-Assembled Human Endomysial-Type Biomatrix Substrate for the Detection of Celiac Disease Autoantibodies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031012
Vancouver
Korponay-Szabó IR, Király R, Gyimesi J, Mäki M. Development of Cell-Assembled Human Endomysial-Type Biomatrix Substrate for the Detection of Celiac Disease Autoantibodies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031012
BibTeX
@article{KorponaySzab2025,
author = {Korponay-Szabó, Ilma R and Király, Róbert and Gyimesi, Judit and Mäki, Markku},
title = {Development of Cell-Assembled Human Endomysial-Type Biomatrix Substrate for the Detection of Celiac Disease Autoantibodies},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26031012}
}
EUVIMED